Replies to post #330005 on Avid Bioservices Inc (CDMO)

[biopharm]

More interesting is the sell from Bandera about the same buy from our latest hedge fund Roubaix Capital

Maybe Madeline Elaine Hedges (Chief Compliance Officer) with Bandera now for a couple months may know ( ex Dinsmore & Shohl LLP who has exosome patent clients etc )

Exosomes are alive and well in demand if one has the patents

Bandera to Roubaix and now forced to sell for some reason....very interesting

Almost as odd as it was to see Joel McComb just up and leave

Looks like some are forced to sell and some are forced to resign

Who is next?

Who will be the big name added to the BOD?

I wonder if Joel McComb is doing well lately with Point Break Capital hedge fund

The next BOD entrance should happen before the next cc and before revisions made to increase guidance revenue and result in decent stock options awards